“Selectivity Barriers in the Therapeutic Target Validation of β-Secretase-1 in the Pathogenesis of Alzheimer’s Disease: Review Article”, JOPIR, vol. 4, no. 3, pp. 066–098, Jun. 2026, doi: 10.69613/jvyw7v28.